| Tretinoin | Approved Investigational Nutraceutical | FOS | 2353 |
upregulated | Tretinoin results in increased expression of FOS mRNA | 14q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FOSB | 2354 |
upregulated | Tretinoin results in increased expression of FOSB mRNA | 19q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | FOSL2 | 2355 |
upregulated | Tretinoin results in increased expression of FOSL2 mRNA | 2p23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXA1 | 3169 |
upregulated | Tretinoin results in increased expression of FOXA1 mRNA | 14q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXA2 | 3170 |
upregulated | Tretinoin results in increased expression of FOXA2 mRNA | 20p11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXC1 | 2296 |
upregulated | Tretinoin results in increased expression of FOXC1 mRNA | 6p25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXC2 | 2303 |
upregulated | Tretinoin results in increased expression of FOXC2 mRNA | 16q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXG1 | 2290 |
downregulated | Tretinoin results in decreased expression of FOXG1 mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXJ2 | 55810 |
upregulated | Tretinoin results in increased expression of FOXJ2 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXL1 | 2300 |
upregulated | Tretinoin results in increased expression of FOXL1 mRNA | 16q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXL2 | 668 |
upregulated | Tretinoin results in increased expression of FOXL2 mRNA | 3q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXN3 | 1112 |
upregulated | Tretinoin results in increased expression of FOXN3 mRNA | 14q31.3-q32.11 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXN3-AS1 | 400236 |
downregulated | Tretinoin results in decreased expression of FOXN3-AS1 mRNA | 14q32.11 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXO1 | 2308 |
upregulated | Tretinoin results in increased expression of FOXO1 mRNA | 13q14.11 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXO3 | 2309 |
upregulated | Tretinoin results in increased expression of FOXO3 mRNA | 6q21 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXO4 | 4303 |
upregulated | Tretinoin results in increased expression of FOXO4 mRNA | Xq13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXP1 | 27086 |
upregulated | Tretinoin results in increased expression of FOXP1 mRNA | 3p13 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXP2 | 93986 |
upregulated | Tretinoin results in increased expression of FOXP2 mRNA | 7q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FOXRED2 | 80020 |
downregulated | Tretinoin results in decreased expression of FOXRED2 mRNA | 22q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FRAS1 | 80144 |
downregulated | Tretinoin results in decreased expression of FRAS1 mRNA | 4q21.21 | |
| Tretinoin | Approved Investigational Nutraceutical | FRAS1 | 80144 |
upregulated | Tretinoin results in increased expression of FRAS1 mRNA | 4q21.21 | |
| Tretinoin | Approved Investigational Nutraceutical | FRAT2 | 23401 |
downregulated | Tretinoin results in decreased expression of FRAT2 mRNA | 10q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FREM1 | 158326 |
downregulated | Tretinoin results in decreased expression of FREM1 mRNA | 9p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FREM1 | 158326 |
upregulated | Tretinoin results in increased expression of FREM1 mRNA | 9p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FREM2 | 341640 |
upregulated | Tretinoin results in increased expression of FREM2 mRNA | 13q13.3 | |